Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Atypical Squamous Cells of the Cervix (Phase 4)
Bifidobacterium (Phase 2/Phase 3)
Breast Neoplasms (Phase 2)
Colic (Phase 2)
Drug Resistant Epilepsy (Phase 2)
Eczema (Phase 3)
Gastrointestinal Microbiome (Phase 2/Phase 3)
Glutamine (Phase 2/Phase 3)
Microbiota ()
Papillomavirus Infections (Phase 4)
Probiotics (Phase 2/Phase 3)
Proctitis (Phase 2/Phase 3)
Squamous Intraepithelial Lesions (Phase 4)
Vaginal Diseases (Phase 4)
Vaginosis, Bacterial (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue